- Additional Authors
- Description
- 1 online resource (iii, 78 pages) : illustrations
- Summary
- Anemia is very common in congestive heart failure (CHF) and coronary heart disease (CHD) patients. Anemia in CHF and CHD patients is associated with poorer outcomes, including an increased risk of hospitalization, decreased exercise capacity, and poor quality of life. Despite the association with poorer outcomes, it is unclear whether treating anemia or iron deficiency will improve outcomes. Anemia treatment strategies in heart failure and CHD patients include erythropoiesis-stimulating agents (ESAs) and red blood cell transfusions. Iron replacement in iron deficient patients with or without anemia has also been investigated. The objective of this evidence review is to evaluate the balance of benefit and harms of these treatments.
- Subject
- Genre/Form
- Technical reports.
- Note
- "Evidence-based synthesis program."
- "October 2011."
- Bibliography (note)
- Includes bibliographical references (pages 49-55).
- Funding (note)
- Prepared for: Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service, Washington, DC 20420. Prepared by: Evidence-based Synthesis Program (ESP) Center, Portland VA Medical Center, Portland, OR, Devan Kansagara, M.D., M.C.R., Director.
- VA-ESP
- Source of Description (note)
- Description based on online resource; title from PDF cover (VA, viewed April 30, 2021).
- Call Number
- GPO Internet VA 1.107/3:AN 3
- OCLC
- marcive793073726
- Author
Kansagara, Devan, author.
- Title
Treatment of anemia in patients with heart disease : a systematic review / Devan Kansagara [and four others].
- Publisher
Washington, DC : Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service, 2011.
- Type of Content
text
- Type of Medium
computer
- Type of Carrier
online resource
- Bibliography
Includes bibliographical references (pages 49-55).
- Funding
Prepared for: Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service, Washington, DC 20420. Prepared by: Evidence-based Synthesis Program (ESP) Center, Portland VA Medical Center, Portland, OR, Devan Kansagara, M.D., M.C.R., Director.
VA-ESP 05-225
- Connect to:
- Added Author
United States. Department of Veterans Affairs. Health Services Research and Development Service, issuing body.
Portland VA Medical Center. Evidence-based Synthesis Program Center.
Evidence-based Synthesis Program (U.S.)
- Gpo Item No.
0985-A-12 (online)
- Sudoc No.
VA 1.107/3:AN 3